To this end, we used immunofluorescence and immunohistochemistry to examine the expression profiles of FHL2 and sPmel17 in UVB-treated tail skin of Dct-LacZ transgenic mice and the repigmented lesional skins from vitiligo patients who underwent UVB therapy. This evidence concerns the gene DCT and vitiligo.